Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03478462
Brief Title: Dose Escalation Study of CLR 131 in Children, Adolescents, and Young Adults With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma (CLOVER-2)

First Submitted : March 20, 2018
First Submitted that Met QC Criteria : March 26, 2018
First Posted : March 27, 2018

Last Update Submitted that Met QC Criteria : August 3, 2021
Last Update Posted : August 5, 2021